|
||
| |||||||
|
|
EU Project aims to accelerate transfer from research to routine use of urgently needed new methods through European network of accredited evaluation centres Leuven, January 18th, 2006, EuroGentest, the European Network of Excellence aiming at harmonizing genetic testing services throughout Europe, today announced an urgent ‘Call for new Innovative Techniques in Genome Diagnostics’. One of the key objectives of the 5-year EU-funded project is to bridge the gap observed in the chain of new technology transfer from research into routine use in genetic diagnostics. To address this, EuroGentest Unit 5 has been formed to coordinate all the activities required for accelerated technical evaluation, validation and subsequent implementation of new technologies into clinical practice. Responses to the call will be used to help build a web-based inventory of new techniques and also discussed in an open satellite workshop at the ESHG meeting in May. Bert Bakker and Nienke van der Stoep, of the Center for Human and Clinical Genetics at the Leiden University Medical Center who are involved in Unit 5, say the timing of the call is no accident: “At present, the field of genetics is witnessing an impressive expansion of new technologies, including not only new advanced high throughput and micro-array approaches, but also straightforward yet highly sensitive detection-assays for DNA mutations and genome copy-number changes. As geneticists we see that several of these technical developments could have real potential to improve genetic testing.” With this in mind, EuroGentest Unit 5 intends to acquire a comprehensive inventory of all the latest technological developments in genetic testing and to coordinate their technical evaluation through a network of accredited Diagnostic Centres all over Europe using well-characterized clinical samples. Bakker and van der Stoep believe that introducing such a coordinated introduction and evaluation of various new techniques in different Diagnostic Centres in place of the adhoc informal system that exists currently will not only improve the technical evaluation process, but will also speed up subsequent validation procedures and implementation of new genetic tests. “We would also hope such a transparent system would increase public acceptance and uptake of tests. Therefore we are now making a web-based call for “Innovative Techniques in Genome Diagnostics” at our Unit 5 homepage. We invite both academic and industrial research groups to introduce and assess their latest developments through expert diagnostic laboratories. We aim to build an inventory of the new techniques with open access to complement our list of existing techniques we are trialling currently with EuroGentest members,” continue Bakker and van der Stoep. As part of this initiative, EuroGentest will also be hosting a Satellite meeting on “Innovative Techniques in Genome Diagnostics” at the ESHG in May 2006. At this meeting EuroGentest will provide a platform where companies and academic research groups can interact and present their new techniques in genetic testing and receive feedback. More information and application details can be found on the EuroGentest Unit 5 homepage. (http://www.eurogentest.org/cocoon/egtorg/web/info/homepage/unit5v2.xhtml) EuroGentest is headed by Professor Jean-Jacques Cassiman who believes the timing of the project is important: “Genetic testing is growing at between 200 and 300% per annum with tests for over 1000 conditions currently offered. In addition we are rapidly moving into the era of pharmacogenetics and personalized medicine. It is essential this is done in structured way with the public able to maintain complete confidence in the quality of testing and counseling being provided. This is quite a challenge, and can only practically be tackled through a collaborative effort supported by the EU.” -Ends- Notes to editors EuroGentest is an EU-funded project (10 million Euro for 5 years) that aims to establish an NoE (Network of Excellence) in genetic testing. Started in January 2005 the project is coordinated by Professor Jean-Jacques Cassiman, an acknowledge world expert in CF testing who holds the Arthur Bax and Anna Vanluffelen chair of Human Genetics at the Center for Human Genetics in Leuven, Belgium. The project is divided into 6 units each with a number of working parties. More information is available at www.eurogentest.org Facts and figures No of testing centres in Europe – 1500 Number of conditions tested >1000 Annual growth in testing - 100-300% Number of people in the EU suffering from genetic disease > 30 million Cost to EU health sector – EUROS 500 million
|
| ||||||||||||||||
| ||||||||
